| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Depression > The Anxiety Depression Connection |
|
E-Articles - The Anxiety Depression Connection
Depression is normally thought of as a low energy state of being and is often times According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product linked with a partner in crime known as... anxiety. Depending on the individual c ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in se at hand, depressed individuals, over time may develop feelings of helplessness a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. bout being depressed all of the time; so they end up suffering from feelings of anx here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ety. And then... other times it is the anxiety that arrives first. Over time the a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro xiety begins to develop into depression. This occurs because the individual begins ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc to feel as though they are trapped into these anxious feelings with no way to escap easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi . As a general rule of thumb however, depression and anxiety disorders are two com nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically letely separate entities. Often times, the two can become confused due to the simil and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ arities in the way the two are treated. A lot of times people suffering from the t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi o disorders are prescribe the same anti-depressants and anti-anxiety medications. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a recent University study found that 85% of all major depression cases, excluding b dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ipolar disorder, are partnered up with symptoms of mild to acute anxiety. For the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ost part, the anxiety portion of combination symptoms comes as a diagnosis of gener tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen lized anxiety disorder. They also found that 35% of this group had symptoms of pani t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel c disorder. Anxiety and depression have been partnering up so often that they are ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust onsidered to be the "linked twins" as far as the big mood disorders go. And sadly, y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products hen depression and anxiety combine forces they are often more powerful and harder t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de o control. A large number of people that suffer from the two disorders often claim elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip that it is the anxiety that is the toughest... most lingering part of their ailment tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:2 Great Ways To Save Money - By Rounding Up And By Rounding Down
|